Early Detection of Prostate Cancer Using PDL-1 and IL-6 In Najaf Al-Ashraf Governorate
Medical Science Journal for Advance Research · 28.02.2026 · 6 (4)
DOI: 10.46966/msjar.v6i4.352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Journal for Advance Research, online erschienen am 28.02.2026. Verfasst von Qassim. M. Hashym und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The current study, collected 240 samples blood divided into first group was a healthy which included man (60) while second group interested patients of prostate cancer from (180) man and by used ELAISA techniques for prognosis prostate cancer by serum parameters programmed cell death-ligand 1 (PDL-1) , Interleukin 6 (IL-6) is an interleukin that acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine. The statistical results of the immune markers (PDL-1, IL-6) when (180) samples collected from patients and (60) healthy showed relationship with cancer when compared with the results of healthy people. It was highly significant and p. Value
Zitieren
APA
Hashym, Q. M., & Almosawi, S. M. J. (2026). Early Detection of Prostate Cancer Using PDL-1 and IL-6 In Najaf Al-Ashraf Governorate. Medical Science Journal for Advance Research, 6(4). https://doi.org/10.46966/msjar.v6i4.352
Vancouver
Hashym QM, Almosawi SMJ. Early Detection of Prostate Cancer Using PDL-1 and IL-6 In Najaf Al-Ashraf Governorate. Medical Science Journal for Advance Research. 2026;6(4). doi:10.46966/msjar.v6i4.352
BibTeX
@article{Hashym2026,
author = {Hashym, Qassim. M. and Almosawi, Sadeq Mohammad Jaafar},
title = {Early Detection of Prostate Cancer Using PDL-1 and IL-6 In Najaf Al-Ashraf Governorate},
journal = {Medical Science Journal for Advance Research},
year = {2026},
volume = {6},
number = {4},
doi = {10.46966/msjar.v6i4.352}
}
EUVIMED